Join us for a congressional briefing via Zoom on Wednesday, March 17, 2021 to address Advancing Health Outcomes for Women and Minorities.
- Linda Greub, C.F.A., M.B.A. | General Partner, Avestria
- Valerie Palmieri | President and CEO, Aspira Women's Health
- Roberta Powell, M.P.H., RN, PhD Candidate | Founder, Q2Q Health
- Kathryn G. Schubert, M.P.P. | President and CEO, Society for Women's Health Research
There are biological and genetic differences that impact women’s health, and the underrepresentation of women and minorities in research is contributing to a lack of data, understanding, investment and innovation to address diseases/conditions that exclusively, disproportionately or differentially impact women. For example, adverse drug events are twice as common for women, and approximately a fifth of new drugs approved between 2008 and 2013 demonstrated differences in exposure and/or drug response across racial/ethnic groups, according to the FDA. In addition, little to no research is conducted on improving health outcomes for women who are pregnant, postpartum and throughout the entire first year of her newborn's life. African American women across the socioeconomic spectrum are dying from preventable pregnancy-related complications at three to four times the rate of non-Hispanic white women, while the death rate for Black infants is twice that of infants born to non-Hispanic white mothers, according to the CDC. These are just some of the systemic obstacles contributing to significant and avoidable safety and efficacy issues for female and minority populations.
We can change this.
Join us, the Women's Health Innovation Coalition and Springboard as we educate lawmakers, staff, agencies and the public on these issues and work to change policies for the better. RSVP using the registration link or email kbrown@G2Gconsulting.com to RSVP.